{"entity":{"id":"be56d4e3-e5fa-58dd-83a4-8becb67d3b52","name":"THIEL CARSTEN","type":"Company","kind":"company","jurisdiction":"US","identifier":"sec:0001633582","risk":"LOW","flags":[],"registry_profile":null},"identity":{"linked_records":[],"also_known_in":[]},"ownership":{"direct_owners":[],"holdings":[{"role":"director","share":null,"subsidiary":{"id":"d3cdfe0f-33f7-546c-a301-1cfef18386a8","name":"Karyopharm Therapeutics Inc.","type":"Company","kind":"company","identifier":"sec:0001503802"}},{"role":"officer","share":null,"subsidiary":{"id":"e34b727b-1361-5b27-b969-093f1afea9ee","name":"ABEONA THERAPEUTICS INC.","type":"Company","kind":"company","identifier":"sec:0000318306"}},{"role":"officer","share":null,"subsidiary":{"id":"7842a64d-6d8c-59e1-82ea-575c4c24b5fa","name":"ALEXION PHARMACEUTICALS INC","type":"Company","kind":"company","identifier":"sec:0000899866"}}],"ubo_chain":[]},"risk":{"level":"LOW","flags":[],"note":"Risk is a layer-1 signal (offshore-layering / connectivity heuristics) — an investigative lead, not a determination."},"financials":null,"sources":[],"access":{"tier":"free","note":"Free tier: identity, cross-source links, 1-hop subsidiaries, risk/sanctions, latest financials and provenance. The full multi-hop UBO chain, itemised assets (vessels/aircraft/securities/real estate) and financial history unlock with a paid API key or a one-off dossier — whiteintel.dev/pricing."},"source":"corpus"}